Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014997028> ?p ?o ?g. }
- W3014997028 endingPage "e202051" @default.
- W3014997028 startingPage "e202051" @default.
- W3014997028 abstract "<h3>Importance</h3> Benzodiazepines, which are associated with safety-related harms for older adults, were not covered when the US Medicare Part D prescription drug benefit began. Coverage was extended to benzodiazepines in 2013. <h3>Objective</h3> To examine whether the expansion of benzodiazepine coverage among Medicare Advantage (MA) beneficiaries was associated with increases in fall-related injuries or overdoses among older adults. <h3>Design, Setting, and Participants</h3> This ecological study used interrupted time-series with comparison-series analyses of MA claims data from 4 635 312 age-eligible MA beneficiaries and 940 629 commercially insured individuals (comparison group) stratified by age (65-69, 70-74, 75-79, and ≥80 years) to separately compare trends in fall-related injury and overdose before (January 1, 2010, to December 31, 2012) and after (January 1, 2013, to December 31, 2015) coverage expansion for benzodiazepines. Data analysis was performed from September 1, 2018, to August 31, 2019. <h3>Exposures</h3> Expansion of benzodiazepine coverage in Medicare Part D in 2013. <h3>Main Outcomes and Measures</h3> Monthly rate of fall-related injury and overdose. <h3>Results</h3> In 2012 (the year before the policy change), women constituted 57.5% of the MA group and 47.4% of the comparison group. A total of 25.8% of individuals in the MA group were aged 65 to 69 years, and 29.3% were 80 years or older (mean [SD], 75.1 [6.4] years); 56.7% of individuals in the comparison group were aged 65 to 69 years, and 15.1% were 80 years or older (mean [SD] age, 70.9 [6.5] years). In the MA group, 4 635 312 individuals contributed 156 754 749 person-months from 2010 through 2015; in the comparison group, 940 629 individuals contributed 25 104 534 person-months. After coverage of benzodiazepines began, the rate (ie, slope) of fall-related injury among MA beneficiaries increased from before to after coverage among all age groups. Compared with the comparison group, the increase in rate was statistically significant for those 80 years or older (rate changes for the MA vs comparison groups: 0.12 [95% CI, 0.07 to 0.17] vs −0.01 [95% CI, −0.11 to 0.10];<i>P</i> = .04 for interaction). The overdose trend changed from decreasing to increasing among MA beneficiaries after coverage for all age groups, with a statistically significant increase compared with the comparison group among those aged 65 to 69 years (rate changes for the MA vs comparison groups: 0.23 [95% CI, 0.17 to 0.30] vs 0.02 [95% CI, −0.06 to 0.11];<i>P</i> < .001 for interaction) and among those 80 years or older (rate changes for the MA vs comparison groups: 0.07 [95% CI, 0.00 to 0.14] vs −0.20 [95% CI, −0.35 to −0.05];<i>P</i> = .002 for interaction). Results among MA beneficiaries were consistent when stratified by sex and when limited to those prescribed opioids. <h3>Conclusions and Relevance</h3> Medicare’s expansion of benzodiazepine coverage may have been associated with increases in the rates of overdose among adults ages 65 to 69 years and in the rates of overdose and fall-related injury among those 80 years or older." @default.
- W3014997028 created "2020-04-10" @default.
- W3014997028 creator A5010070591 @default.
- W3014997028 creator A5028538148 @default.
- W3014997028 creator A5031807571 @default.
- W3014997028 creator A5032332498 @default.
- W3014997028 creator A5048830947 @default.
- W3014997028 creator A5061950652 @default.
- W3014997028 date "2020-04-03" @default.
- W3014997028 modified "2023-10-17" @default.
- W3014997028 title "Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries" @default.
- W3014997028 cites W1539210069 @default.
- W3014997028 cites W1845987094 @default.
- W3014997028 cites W1978107278 @default.
- W3014997028 cites W1997402220 @default.
- W3014997028 cites W1999104204 @default.
- W3014997028 cites W2015667356 @default.
- W3014997028 cites W2015921607 @default.
- W3014997028 cites W2017489491 @default.
- W3014997028 cites W2031865939 @default.
- W3014997028 cites W2038389290 @default.
- W3014997028 cites W2043475910 @default.
- W3014997028 cites W2054231989 @default.
- W3014997028 cites W2099219820 @default.
- W3014997028 cites W2106292851 @default.
- W3014997028 cites W2112001002 @default.
- W3014997028 cites W2121647405 @default.
- W3014997028 cites W2157318351 @default.
- W3014997028 cites W2163278718 @default.
- W3014997028 cites W2167924686 @default.
- W3014997028 cites W2232029475 @default.
- W3014997028 cites W2241751268 @default.
- W3014997028 cites W2257575319 @default.
- W3014997028 cites W2281412879 @default.
- W3014997028 cites W2310115806 @default.
- W3014997028 cites W2413328575 @default.
- W3014997028 cites W2563326706 @default.
- W3014997028 cites W2597966538 @default.
- W3014997028 cites W2805664586 @default.
- W3014997028 cites W2809119374 @default.
- W3014997028 cites W2917057188 @default.
- W3014997028 cites W2974382724 @default.
- W3014997028 cites W2975621114 @default.
- W3014997028 cites W2983452423 @default.
- W3014997028 cites W3000476738 @default.
- W3014997028 cites W4200337926 @default.
- W3014997028 cites W4230829152 @default.
- W3014997028 cites W4235645362 @default.
- W3014997028 cites W4238410761 @default.
- W3014997028 cites W4239986561 @default.
- W3014997028 cites W4241984066 @default.
- W3014997028 cites W4243569349 @default.
- W3014997028 cites W4250081944 @default.
- W3014997028 doi "https://doi.org/10.1001/jamanetworkopen.2020.2051" @default.
- W3014997028 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7125434" @default.
- W3014997028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32242907" @default.
- W3014997028 hasPublicationYear "2020" @default.
- W3014997028 type Work @default.
- W3014997028 sameAs 3014997028 @default.
- W3014997028 citedByCount "6" @default.
- W3014997028 countsByYear W30149970282020 @default.
- W3014997028 countsByYear W30149970282021 @default.
- W3014997028 countsByYear W30149970282022 @default.
- W3014997028 crossrefType "journal-article" @default.
- W3014997028 hasAuthorship W3014997028A5010070591 @default.
- W3014997028 hasAuthorship W3014997028A5028538148 @default.
- W3014997028 hasAuthorship W3014997028A5031807571 @default.
- W3014997028 hasAuthorship W3014997028A5032332498 @default.
- W3014997028 hasAuthorship W3014997028A5048830947 @default.
- W3014997028 hasAuthorship W3014997028A5061950652 @default.
- W3014997028 hasBestOaLocation W30149970281 @default.
- W3014997028 hasConcept C126322002 @default.
- W3014997028 hasConcept C144024400 @default.
- W3014997028 hasConcept C149923435 @default.
- W3014997028 hasConcept C170493617 @default.
- W3014997028 hasConcept C194828623 @default.
- W3014997028 hasConcept C2426938 @default.
- W3014997028 hasConcept C2778173252 @default.
- W3014997028 hasConcept C71924100 @default.
- W3014997028 hasConcept C98274493 @default.
- W3014997028 hasConceptScore W3014997028C126322002 @default.
- W3014997028 hasConceptScore W3014997028C144024400 @default.
- W3014997028 hasConceptScore W3014997028C149923435 @default.
- W3014997028 hasConceptScore W3014997028C170493617 @default.
- W3014997028 hasConceptScore W3014997028C194828623 @default.
- W3014997028 hasConceptScore W3014997028C2426938 @default.
- W3014997028 hasConceptScore W3014997028C2778173252 @default.
- W3014997028 hasConceptScore W3014997028C71924100 @default.
- W3014997028 hasConceptScore W3014997028C98274493 @default.
- W3014997028 hasIssue "4" @default.
- W3014997028 hasLocation W30149970281 @default.
- W3014997028 hasLocation W30149970282 @default.
- W3014997028 hasLocation W30149970283 @default.
- W3014997028 hasLocation W30149970284 @default.
- W3014997028 hasOpenAccess W3014997028 @default.
- W3014997028 hasPrimaryLocation W30149970281 @default.
- W3014997028 hasRelatedWork W1975726562 @default.
- W3014997028 hasRelatedWork W2044258220 @default.